RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
66 hedge funds and large institutions have $131M invested in Ra Pharmaceuticals, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
43% less capital invested
Capital invested by funds: $230M → $131M (-$98.7M)
Holders
66
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.03M | |
| 2 | +$2.62M | |
| 3 | +$850K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$397K |
| 5 |
PP
PDT Partners
New York
|
+$394K |
Top Sellers
| 1 | -$4.06M | |
| 2 | -$3.43M | |
| 3 | -$1.91M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.78M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
-$1.64M |